Linglin Feng

1.0k total citations
26 papers, 831 citations indexed

About

Linglin Feng is a scholar working on Molecular Biology, Pharmaceutical Science and Biomedical Engineering. According to data from OpenAlex, Linglin Feng has authored 26 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Pharmaceutical Science and 5 papers in Biomedical Engineering. Recurrent topics in Linglin Feng's work include RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). Linglin Feng is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). Linglin Feng collaborates with scholars based in China, United States and Canada. Linglin Feng's co-authors include Weiyue Lu, Changyou Zhan, Jianhua Zhu, Yu Liu, Xiaoli Wei, Cao Xie, Gang Wei, Zhiqiang Yan, Jun Qian and Fei Wang and has published in prestigious journals such as Chemical Communications, Journal of Controlled Release and Small.

In The Last Decade

Linglin Feng

26 papers receiving 817 citations

Peers

Linglin Feng

BIOMA

ONCOL

Yayuan Liu China

Seyedeh Alia Moosavian Iran

Jiayi Pan United States

Kaushik Kuche India

Ankur Kaul India

Sohee Son South Korea

Shu-di Yang China

Dae Hwan Shin South Korea

Inmaculada Conejos‐Sánchez Spain

Donghang Xu China

Yayuan Liu China

Linglin Feng

585 ×1.4

521 ×1.3

BIOMA

317 ×1.2

120 ×0.8

87 ×0.9

ONCOL

Citations per year, relative to Linglin Feng Linglin Feng (= 1×) peers Yayuan Liu

Countries citing papers authored by Linglin Feng

Since Specialization

Citations

This map shows the geographic impact of Linglin Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linglin Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linglin Feng more than expected).

Fields of papers citing papers by Linglin Feng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linglin Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linglin Feng. The network helps show where Linglin Feng may publish in the future.

Co-authorship network of co-authors of Linglin Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Linglin Feng. A scholar is included among the top collaborators of Linglin Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linglin Feng. Linglin Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pan, Feng, Yilin Guo, Yanhong Zhao, et al.. (2023). Evaluation the injectability of injectable microparticle delivery systems on the basis of injection force and discharged rate. European Journal of Pharmaceutics and Biopharmaceutics. 190. 58–72. 8 indexed citations

Zeng, Jia, et al.. (2022). Preparation and In Vitro and In Vivo Evaluation of a Testosterone Film Forming Gel for the Treatment of Hypoactive Sexual Desire Disorder in Women. AAPS PharmSciTech. 23(3). 79–79. 2 indexed citations

Wang, Jun, Li Sui, Linglin Feng, et al.. (2021). Enhanced mucosal penetration and efficient inhibition efficacy against cervical cancer of PEGylated docetaxel nanocrystals by TAT modification. Journal of Controlled Release. 336. 572–582. 35 indexed citations

Beig, Avital, Linglin Feng, Jennifer Walker, et al.. (2021). Development and characterization of composition-equivalent formulations to the Sandostatin LAR® by the solvent evaporation method. Drug Delivery and Translational Research. 12(3). 695–707. 9 indexed citations

Beig, Avital, Linglin Feng, Jennifer Walker, et al.. (2020). Physical–Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres. Molecular Pharmaceutics. 17(11). 4141–4151. 32 indexed citations

Li, Fang, et al.. (2019). <p>siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo</p>. Drug Design Development and Therapy. Volume 13. 757–766. 6 indexed citations

Li, Fang, et al.. (2018). Fenofibrate modified-release pellets with lag phase and high oral bioavailability. Drug Design Development and Therapy. Volume 13. 141–151. 5 indexed citations

Tai, Lingyu, Chang Liu, Kuan Jiang, et al.. (2017). A novel penetratin-modified complex for noninvasive intraocular delivery of antisense oligonucleotides. International Journal of Pharmaceutics. 529(1-2). 347–356. 31 indexed citations

Liu, Yu, Linglin Feng, Yang Long, et al.. (2017). In vivo retention of poloxamer-based in situ hydrogels for vaginal application in mouse and rat models. Acta Pharmaceutica Sinica B. 7(4). 502–509. 50 indexed citations

10.

Su, Tingting, et al.. (2014). Construction of a two-in-one liposomal system (TWOLips) for tumor-targeted combination therapy. International Journal of Pharmaceutics. 476(1-2). 241–252. 9 indexed citations

11.

Feng, Linglin, et al.. (2013). Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy. Asian Journal of Pharmaceutical Sciences. 8(2). 118–127. 27 indexed citations

12.

Zhan, Changyou, Xiaoli Wei, Jun Qian, et al.. (2012). Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo. Journal of Controlled Release. 160(3). 630–636. 87 indexed citations

13.

Yan, Zhiqiang, Fei Wang, Ziyi Wen, et al.. (2011). LyP-1-conjugated PEGylated liposomes: A carrier system for targeted therapy of lymphatic metastatic tumor. Journal of Controlled Release. 157(1). 118–125. 123 indexed citations

14.

Yan, Huihui, Jiyao Wang, Peiwei Yi, et al.. (2011). Imaging brain tumor by dendrimer-based optical/paramagnetic nanoprobe across the blood-brain barrier. Chemical Communications. 47(28). 8130–8130. 58 indexed citations

15.

Yan, Zhiqiang, Changyou Zhan, Ziyi Wen, et al.. (2011). LyP-1-conjugated doxorubicin-loaded liposomes suppress lymphatic metastasis by inhibiting lymph node metastases and destroying tumor lymphatics. Nanotechnology. 22(41). 415103–415103. 51 indexed citations

16.

Huang, Ting, Zhong‐Ze Fang, Yanyan Zhang, et al.. (2011). Inhibitory potential of chlormadinone acetate (CMA) on five important UDP-glucuronosyltransferases in human liver.. PubMed. 66(3). 212–5. 7 indexed citations

17.

Zhan, Changyou, et al.. (2010). Cyclic RGD-poly(ethylene glycol)-polyethyleneimine is more suitable for glioblastoma targeting gene transferin vivo. Journal of drug targeting. 19(7). 573–581. 19 indexed citations

18.

Feng, Linglin, Lei Zhang, Min Liu, et al.. (2009). Roles of dextrans on improving lymphatic drainage for liposomal drug delivery system. Journal of drug targeting. 18(3). 168–178. 22 indexed citations

19.

Liu, Jing, Min Liu, Cao Xie, et al.. (2009). 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: Preparation and evaluation in vitro. International Journal of Pharmaceutics. 372(1-2). 125–131. 81 indexed citations

20.

Feng, Linglin, et al.. (2004). Simultaneous RP-HPLC determination of resveratrol and piceid in polygonum cuspidatum Sieb.et Zucc. Tianran chanwu yanjiu yu kaifa. 16(6). 534–538. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact